Clinical Trial Update: Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma [NA]

View source ↗

Summary

A trial is investigating consolidative radiotherapy to block oligoprogression in metastatic melanoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Metastatic Melanoma, OligoProgressive Metastatic Disease | NA | Status: RECRUITING